• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medications during breastfeeding and pregnancy is a difficult decision for women suffering from the condition. There aren't many studies on how long-term exposure may affect a fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality studies are required.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication should consider the benefits of taking it versus the risks to the foetus. Doctors don't have the necessary data to provide clear recommendations but they can provide information on the risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not face a significantly higher risk of fetal cardiac malformations or major birth defects that are structural. The researchers used a large population-based case-control study to evaluate the incidence of major structural birth defects in infants born to mothers who took stimulants during the early stages of pregnancy, as well as those who had not. Clinical geneticists, pediatric cardiologists and other experts reviewed the cases in order to ensure that the classification was correct and to minimize any bias.

However, the researchers' study was not without its flaws. Most important, they were unable to distinguish the effects of the medication from those of the disorder at hand. This limitation makes it difficult to know whether the small differences observed in the exposed groups are due to medication use or comorbidities that cause confusion. Additionally, the researchers did not examine the long-term effects of offspring on their parents.

The study showed that babies whose mothers took ADHD medication during pregnancy had a slightly higher risk of admission to the neonatal care unit (NICU), compared to mothers who did not take any medication during pregnancy, or had discontinued taking their medication prior to or during pregnancy. This increase was due to central nervous system-related disorders and the increased risk of admission did not appear to be influenced by which stimulant medications were used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher likelihood of having to have an emergency caesarean section or having the baby was not scoring well on the Apgar scale (less than 7). These increases did appear to be independent of the type of medication used during pregnancy.

The research suggests that the small risk associated with the use of ADHD medications during early pregnancy may be offset by the greater benefits to both the mother and child of continuing treatment for the woman's disorder. Physicians should discuss this with their patients and, if possible, help them develop strategies for improving their coping with adhd without medication - more about Longisland - skills which can reduce the impact of her disorder on her daily life and relationships.

Interactions with Medication

More and more doctors are faced with the decision of whether to keep treatment or stop it during pregnancy as more women are diagnosed with ADHD. The majority of these decisions are taken in the absence of clear and authoritative evidence in either case, which means that doctors must weigh what they know about their experiences, the experiences of other doctors, and what research suggests about the subject and their own judgments for each individual patient.

The issue of possible risks to infants is difficult to determine. A lot of studies on this subject are based on observational data instead of controlled research and their findings are often contradictory. most effective adhd medication studies focus on live births, which may underestimate the teratogenic impact which can cause terminations or abortions of pregnancy. The study presented in this journal club addresses these shortcomings by looking at data from both live and deceased births.

Conclusion A few studies have found an association between ADHD medications and certain birth defects however, other studies haven't found a correlation. The majority of studies show that there is a neutral, or somewhat negative, impact. Therefore, a careful risk/benefit assessment must be done in each situation.

It isn't easy, but not impossible, for women suffering from ADHD to stop taking their medication. In a recent piece published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of being isolated. Furthermore, a loss of medication can interfere with the ability to do jobs and drive safely which are essential aspects of daily life for a lot types of adhd medication people with ADHD.

She suggests that women who are not sure whether to continue taking the medication or discontinue it due to pregnancy educate family members, colleagues, and acquaintances about the condition, the effects on daily functioning, and the benefits of keeping the current treatment. It can also aid in ensuring that the woman feels supported as she struggles with her decision. It is important to remember that certain drugs can pass through the placenta, therefore, if a patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she should be aware that the effects of the drug can be passed on to the baby.

Birth Defects and Risk of

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases there are concerns about what impact the medications could have on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this issue. Utilizing two huge data sets researchers were able to examine more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. While the overall risk remains low, the researchers did find that first-trimester exposure to ADHD medications was associated with an increased risk of certain heart defects, such as ventriculo-septal defect (VSD).

The authors of the study could not discover any connection between early medication usage and other congenital anomalies, like facial deformities, or club feet. The results are consistent with previous studies revealing an increase, but not significant, in the risk of developing cardiac malformations among women who started taking ADHD medications prior to the time of the birth of their child. The risk was higher in the latter half of pregnancy, as many women begin to discontinue their ADHD medication.

Women who were taking ADHD medication during the first trimester were more likely require a caesarean birth and also have an insufficient Apgar after delivery, and have a baby who needed breathing assistance after birth. The authors of the study were not able to remove bias in selection since they limited their study to women with no other medical conditions that might have contributed to the findings.

Researchers hope that their study will help doctors when they see pregnant women. They recommend that, while the discussion of the benefits and risks is important however, the decision to stop or maintain treatment should be based on the woman's needs and the severity of her ADHD symptoms.

The authors also warn that even though stopping the medication is an option, it isn't an option to consider due to the high prevalence of depression and other mental health issues among women who are pregnant or recently postpartum. Research has also shown that women who stop taking their medication will have a tough time adjusting to a life without them once the baby is born.

Nursing

It can be a stressful experience to become a mother. Women who suffer from ADHD who have to deal with their symptoms while attending physician appointments as well as getting ready for the arrival of their child and getting used to new routines at home may face a lot of challenges. Many women opt to continue taking their ADHD medication during pregnancy.

The risk to a breastfeeding infant is not too high since the majority of stimulant medication is absorbed through breast milk in low amounts. The rate of exposure to medication will vary based on the dosage the medication is administered, its frequency and the time of the day. In addition, individual medications enter the body of the baby differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn is not fully understood.

Some doctors may stop taking stimulant medication during a woman’s pregnancy due to the absence of research. It is a difficult decision for the mother, who must weigh the benefits of continuing her medication against the potential risks to the embryo. In the meantime, until more information is available, GPs should ask all pregnant patients about their history of ADHD and whether they are planning or taking to take medication during the perinatal period.

A growing number of studies have proven that women can continue their ADHD medication during pregnancy and while breastfeeding. This has led to more and more patients opt to do this, and in consultation with their doctor they have discovered that the benefits of continuing their current medication outweigh any risks.

It's important for women with ADHD who are contemplating breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation should also be provided to help pregnant people with ADHD understand their symptoms and the root cause, learn about available treatment options and strengthen existing strategies for managing. This should involve a multidisciplinary approach with the GP as well as obstetricians, psychiatry and obstetricians. The pregnancy counselling should consist of discussion of a management plan for both the mother and child, monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.